Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study investigates the interplay between PD-L1, FOXP3+ regulatory T cells, and CD8+ cytotoxic T lymphocytes in penile squamous cell carcinoma (penile SCC), where understanding the tumor immune microenvironment is crucial. We analyzed 108 penile SCC specimens using tissue microarrays (528 spots). Immunohistochemistry was performed for PD-L1, FOXP3, and CD8. Expression was quantified in tumor and stromal compartments, and correlated with clinicopathological features including histological grade, HPV-associated morphology, and host inflammatory response. PD-L1 in tumor cells positively correlated with intratumoral CD8+ (rho = 0.408,  < .001) and FOXP3+ T cells (rho = 0.293,  = .009). Peritumoral FOXP3+ and CD8+ T cells also showed a strong correlation (rho = 0.753,  < .001). Higher PD-L1 and intratumoral CD8+ were associated with higher histological grade ( < .001). HPV-associated morphology correlated with higher PD-L1 ( < .001) but lower FOXP3+ infiltration ( < .001). Intense inflammatory response was associated with increased peritumoral FOXP3+ and CD8+ T cells ( < .001). The immune microenvironment of penile SCC involves complex interactions among PD-L1, FOXP3+, and CD8+, and was significantly influenced by histological grade, HPV status, and inflammation. The strong co-localization of peritumoral regulatory and cytotoxic T cells suggests a critical regulatory axis. These findings highlight distinct immune profiles within penile SCC, offering insights for developing tailored immunotherapeutic strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1177/10668969251361176DOI Listing

Publication Analysis

Top Keywords

interplay pd-l1
8
pd-l1 foxp3
8
foxp3 cd8
8
immune microenvironment
8
penile squamous
8
squamous cell
8
cell carcinoma
8
penile scc
8
cd8 immune
4
penile
4

Similar Publications

Lung cancer, particularly non-small cell lung cancer, is a leading cause of global mortality, with many cases diagnosed at advanced stages. The Toll-Like Receptor (TLR) signaling pathway plays a crucial role in linking inflammation to lung cancer progression, with both pro-tumor and anti-tumor effects. This perspective delves into the complex functions of TLR proteins in lung cancers, elucidating their involvement in tumor growth, angiogenesis, and metastasis.

View Article and Find Full Text PDF

This study investigates the interplay between PD-L1, FOXP3+ regulatory T cells, and CD8+ cytotoxic T lymphocytes in penile squamous cell carcinoma (penile SCC), where understanding the tumor immune microenvironment is crucial. We analyzed 108 penile SCC specimens using tissue microarrays (528 spots). Immunohistochemistry was performed for PD-L1, FOXP3, and CD8.

View Article and Find Full Text PDF

Elucidating divergent biology in uterine carcinosarcoma.

Transl Oncol

August 2025

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address:

Objectives: Uterine carcinosarcoma (UCS) is an aggressive malignancy characterized by epithelial (C) and mesenchymal (S) components, with complex biology and poor treatment response. This study aims to enhance understanding of UCS through genomic, epigenomic, and transcriptomic analysis.

Methods: Microdissected (C and S) tumor samples were processed for whole-genome sequencing (WGS), RNA-seqencing, and enzymatic methylation sequencing (EM-Seq).

View Article and Find Full Text PDF

Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review.

Pharmaceuticals (Basel)

July 2025

Department of Dermatology, University of Alabama at Birmingham, Birmingham, 1670 University Blvd., VH566A, Birmingham, AL 35294, USA.

: This review discusses the resistance mechanisms in the tumor microenvironment (TME) of malignant melanoma that disrupt the efficacy of immune checkpoint inhibitors (ICIs). In this review, we focus on the roles of immune cells, including tumor-infiltrating lymphocytes (TILs), macrophages, dendritic cells, and other signaling pathways. We explore the interplay between innate and adaptive immunity in the TME and tumor intrinsic resistance mechanisms, such as β-catenin, which has future implications for the usage of ICIs in patients with therapy-resistant tumors.

View Article and Find Full Text PDF

Immunotherapy with immune checkpoint inhibitors has changed the treatment landscape in many solid tumors. Despite the unprecedent success, many patients will develop primary or secondary resistance to treatment or will hold up therapy due to the emerging immune-related toxicity. Traditionally, tissue-based immune biomarkers, such as PD-L1 expression, have been used to select patients who will benefit most from immunotherapy.

View Article and Find Full Text PDF